Clinical Trials in Michigan

Showing 15601-15620 of 16,154 trials

A Pilot Study of Diabetes Risk Reduction Program With WIC Mothers(The Special Supplemental Nutrition Program for Women, Infants, and Children) Overweight WIC Mothers

NCT00944060

1\) to evaluate treatment fidelity of DRRP: study design, training of interventionists, delivery and receipt of the intervention, and application of the intervention in real-life settings; 2) to identify successful strategies for participant recruitment and maintaining active participation; 3) to collect and analyze preliminary indicators of DRRP's effect on dietary intake, physical activity, stress responses, and body weight; and 4) To evaluate sample representativeness of the target audience, implementation and acceptability of DRRP, and attrition rate.

Prevention of Weight Gain

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

East Lansing, Michigan, United States • East Lansing, Michigan, United States

COMPLETEDPhase 283 miles

A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose

NCT00202982

This is a study to test if a new higher dose of Copaxone is more effective in treating relapsing-remitting multiple sclerosis than the currently available 20 mg dose.

Relapse-Remitting Multiple Sclerosis

Teva Branded Pharmaceutical Products R&D, Inc.90 participantsStarted Aug 2003

La Jolla, California, United States • Oceanside, California, United States • Atlanta, Georgia, United States +17 more locations

A Pilot Study of Diabetes Risk Reduction Program With WIC Mothers(The Special Supplemental Nutrition Program for Women, Infants, and Children) Overweight WIC Mothers

A Study to Test the Effectiveness and Safety of a New Higher 40mg Dose of Copaxone® Compared to Copaxone® 20mg, the Currently Approved Dose

Find Trials by Condition in Michigan

Aztreonam for Inhalation (AI) in Patients With Cystic Fibrosis & P. Aeruginosa Infection

Memory Impairment Study (Mild Cognitive Impairment Study)

Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age

A Phase III Trial For Patients With Metastatic Breast Cancer

Neutrophil Gelatinase-associated Lipcalin(NGAL): A Novel Blood Marker for Determining the Risk of Developing Contrast-Induced Nephopathy

Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke

SGS742 in Patients With Mild to Moderate Alzheimer's Disease (AD)

Phase III Trial of Vinflunine Plus Best Supportive Care vs. Best Supportive Care in Patients With Transitional Cell Carcinoma (TCC) of the Urothelial Tract

Minimally Invasive Surgical Therapy for BPH

Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)

Decompression Intervention of Variceal Rebleeding Trial (DIVERT)

A Pilot Clinical Investigation of the Efficacy and Safety of Uracyst® Versus Placebo in Patients With Interstitial Cystitis/Painful Bladder Syndrome.

Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study

North American Study for the Treatment of Refractory Ascites (NASTRA)

Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer

Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome

A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation

Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery